These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The development of preferred provider organizations and its antitrust implications. Maram BS J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825 [TBL] [Abstract][Full Text] [Related]
7. Managed care and antitrust--a guide for provider-sponsored PPOs. Hershey D Trustee; 1993 Sep; 46(9):12-4. PubMed ID: 10128227 [No Abstract] [Full Text] [Related]
8. Preferred provider organizations: an antitrust warning. Sandler AL Group Pract J; 1987; 36(6):41-2, 44. PubMed ID: 10284861 [No Abstract] [Full Text] [Related]
9. Monopolies, Maricopa, and marketing: a case study. Perkins J; Mercer A; McClary C Hosp Health Serv Adm; 1986; 31(4):34-44. PubMed ID: 10277339 [TBL] [Abstract][Full Text] [Related]
10. Physician-operated networks and the new antitrust guidelines. Kuttner R N Engl J Med; 1997 Jan; 336(5):386-91. PubMed ID: 9011808 [No Abstract] [Full Text] [Related]
11. Pharmacy participation in PPOs: an antitrust review. Health Matrix; 1984-1985 Winter; 2(4):35-7. PubMed ID: 10272758 [No Abstract] [Full Text] [Related]
12. An assessment of the anticompetitive effects of preferred provider organizations. Greaney TL; Sindelar JL Inquiry; 1987; 24(4):384-91. PubMed ID: 2961699 [TBL] [Abstract][Full Text] [Related]
13. Federal antitrust agencies send mixed signals to PPOs. Enders RJ Health Care Law Newsl; 1986 Jul; 1(1):12-4. PubMed ID: 10277502 [No Abstract] [Full Text] [Related]
14. Antitrust and the new competition in health care: excerpts. Ginsburg DH Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459 [No Abstract] [Full Text] [Related]
15. More private, less government PPA antitrust action. Burda D Hospitals; 1987 Feb; 61(3):52. PubMed ID: 3804258 [No Abstract] [Full Text] [Related]
16. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny. Allen HS; Rothschild IS Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389 [No Abstract] [Full Text] [Related]
17. Steering clear of an antitrust charge. Trombetta WL Med Econ; 1986 Aug; 63(16):105-9, 112. PubMed ID: 10277667 [No Abstract] [Full Text] [Related]
18. Alternative delivery systems are focus of antitrust scrutiny. Scammon DL; Fuller DA; Sheffet MJ J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715 [No Abstract] [Full Text] [Related]
19. Provider-sponsored ADSs: reducing antitrust liability after Maricopa. Walsh JH; Feller H Spec Law Dig Health Care (Mon); 1985 Apr; 7(2):5-25. PubMed ID: 10270877 [No Abstract] [Full Text] [Related]